298 related articles for article (PubMed ID: 9518541)
1. Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study.
Gallois L; Fiallo M; Garnier-Suillerot A
Biochim Biophys Acta; 1998 Mar; 1370(1):31-40. PubMed ID: 9518541
[TBL] [Abstract][Full Text] [Related]
2. The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids.
Gallois L; Fiallo M; Laigle A; Priebe W; Garnier-Suillerot A
Eur J Biochem; 1996 Nov; 241(3):879-87. PubMed ID: 8944778
[TBL] [Abstract][Full Text] [Related]
3. Permeability of lipid bilayer to anthracycline derivatives. Role of the bilayer composition and of the temperature.
Frézard F; Garnier-Suillerot A
Biochim Biophys Acta; 1998 Jan; 1389(1):13-22. PubMed ID: 9443599
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: circular dichroism studies.
Henry-Toulme N; Stefanska B; Borowski E; Bolard J
Mol Pharmacol; 1988 May; 33(5):574-9. PubMed ID: 3367905
[TBL] [Abstract][Full Text] [Related]
5. The influence of charge and lipophilicity of daunorubicin and idarubicin on their penetration of model biological membranes - Langmuir monolayer and electrochemical studies.
Matyszewska D
Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183104. PubMed ID: 31672546
[TBL] [Abstract][Full Text] [Related]
6. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
Mankhetkorn S; Garnier-Suillerot A
Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
[TBL] [Abstract][Full Text] [Related]
7. Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.
Kuffel MJ; Reid JM; Ames MM
Cancer Chemother Pharmacol; 1992; 30(1):51-7. PubMed ID: 1586980
[TBL] [Abstract][Full Text] [Related]
8. Daunorubicin and doxorubicin molecular interplay with 2D membrane models.
Alves AC; Nunes C; Lima J; Reis S
Colloids Surf B Biointerfaces; 2017 Dec; 160():610-618. PubMed ID: 29028609
[TBL] [Abstract][Full Text] [Related]
9. Structure-dependent complexation of Fe3+ by anthracyclines. 1. The importance of pendent hydroxyl functionality.
Nawara K; McCracken JL; Krysiński P; Blanchard GJ
J Phys Chem B; 2013 Jun; 117(23):6859-67. PubMed ID: 23692060
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics of new anthracyclines].
Robert J
Bull Cancer; 1988; 75(2):167-74. PubMed ID: 3282579
[TBL] [Abstract][Full Text] [Related]
11. Orientation of anthracyclines in lipid monolayers and planar asymmetrical bilayers: a surface-enhanced resonance Raman scattering study.
Heywang C; Saint-Pierre Chazalet M; Masson CM; Bolard J
Biophys J; 1998 Nov; 75(5):2368-81. PubMed ID: 9788932
[TBL] [Abstract][Full Text] [Related]
12. Selectivity of the anthracyclines for negatively charged model membranes: role of the amino group.
Burke TG; Sartorelli AC; Tritton TR
Cancer Chemother Pharmacol; 1988; 21(4):274-80. PubMed ID: 3370735
[TBL] [Abstract][Full Text] [Related]
13. How Fe3+ binds anthracycline antitumour compounds. The myth and the reality of a chemical sphinx.
Fiallo MM; Garnier-Suillerot A; Matzanke B; Kozlowski H
J Inorg Biochem; 1999 Jun; 75(2):105-15. PubMed ID: 10450605
[TBL] [Abstract][Full Text] [Related]
14. Cancer-Targeted Controlled Delivery of Chemotherapeutic Anthracycline Derivatives Using Apoferritin Nanocage Carriers.
Kurzątkowska K; Pazos MA; Herschkowitz JI; Hepel M
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572999
[TBL] [Abstract][Full Text] [Related]
15. Different cytotoxicity and metabolism of doxorubicin, daunorubicin, epirubicin, esorubicin and idarubicin in cultured human and rat hepatocytes.
Le Bot MA; Bégué JM; Kernaleguen D; Robert J; Ratanasavanh D; Airiau J; Riché C; Guillouzo A
Biochem Pharmacol; 1988 Oct; 37(20):3877-87. PubMed ID: 3190734
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of doxorubicin, daunorubicin, and idarubicin by capillary electrophoresis with laser-induced fluorescence detection.
Pérez-Ruiz T; Martínez-Lozano C; Sanz A; Bravo E
Electrophoresis; 2001 Jan; 22(1):134-8. PubMed ID: 11197162
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model.
Berg SL; Reid J; Godwin K; Murry DJ; Poplack DG; Balis FM; Ames MM
J Pediatr Hematol Oncol; 1999; 21(1):26-30. PubMed ID: 10029808
[TBL] [Abstract][Full Text] [Related]
18. Configurational requirements of the sugar moiety for the pharmacological activity of anthracycline disaccharides.
Arcamone F; Animati F; Bigioni M; Capranico G; Caserini C; Cipollone A; De Cesare M; Ettorre A; Guano F; Manzini S; Monteagudo E; Pratesi G; Salvatore C; Supino R; Zunino F
Biochem Pharmacol; 1999 May; 57(10):1133-9. PubMed ID: 11230800
[TBL] [Abstract][Full Text] [Related]
19. Comparison of adriamycin and derivatives uptake into large unilamellar lipid vesicles in response to a membrane potential.
Praet M; Defrise-Quertain F; Ruysschaert JM
Biochim Biophys Acta; 1993 Jun; 1148(2):342-50. PubMed ID: 8504127
[TBL] [Abstract][Full Text] [Related]
20. Structure-dependent complexation of Fe3+ by anthracyclines. 2. The roles of methoxy and daunosamine functionalities.
Nawara K; Beeckman H; Krysiński P; Blanchard GJ
J Phys Chem B; 2013 Jun; 117(23):6868-73. PubMed ID: 23692121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
